Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation | Zendy

Tadeusz Wojciech Łapiński | Zendy

Open Access

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation

Author(s) -

Tadeusz Wojciech Łapiński

Publication year - 2005

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v11.i3.400

Subject(s) - lamivudine , medicine , dialysis , gastroenterology , hbeag , hemodialysis , kidney transplantation , transplantation , creatinine , renal function , kidney disease , kidney , hepatitis b , hbsag , hepatitis b virus , immunology , virus

To analyze the effectiveness and safety of lamivudine treatment in patients with chronic HBV infection undergoing hemodialysis or after kidney transplantation, and to study the frequency of tyrosine-methionine-aspartate-aspartate (YMDD) mutation occurrence after lamivudine treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research